🇺🇸 FDA
Patent

US 11371024

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

granted A61KA61K2039/5254A61K2039/53

Quick answer

US patent 11371024 (Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5254, A61K2039/53, A61K2039/55, A61K39/155